214 related articles for article (PubMed ID: 38001663)
1. Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts).
Hernández Guerrero T; Baños N; Del Puerto Nevado L; Mahillo-Fernandez I; Doger De-Speville B; Calvo E; Wick M; García-Foncillas J; Moreno V
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001663
[No Abstract] [Full Text] [Related]
2. Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts.
Zhuo J; Lu D; Wang J; Lian Z; Zhang J; Li H; Cen B; Wei X; Wei Q; Xie H; Xu X
Chin J Cancer Res; 2021 Aug; 33(4):470-479. PubMed ID: 34584372
[TBL] [Abstract][Full Text] [Related]
3. Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study.
Yu X; Chen Y; Lu J; He K; Chen Y; Ding Y; Jin K; Wang H; Zhang H; Wang H; Teng L
Front Oncol; 2022; 12():985154. PubMed ID: 36465411
[TBL] [Abstract][Full Text] [Related]
4. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
[TBL] [Abstract][Full Text] [Related]
5. Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models.
Shin HY; Lee EJ; Yang W; Kim HS; Chung D; Cho H; Kim JH
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159096
[TBL] [Abstract][Full Text] [Related]
6. Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts.
Okano M; Oshi M; Butash A; Okano I; Saito K; Kawaguchi T; Nagahashi M; Kono K; Ohtake T; Takabe K
J Mammary Gland Biol Neoplasia; 2020 Mar; 25(1):27-36. PubMed ID: 32109311
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
[TBL] [Abstract][Full Text] [Related]
8. Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.
Kanaya N; Somlo G; Wu J; Frankel P; Kai M; Liu X; Wu SV; Nguyen D; Chan N; Hsieh MY; Kirschenbaum M; Kruper L; Vito C; Badie B; Yim JH; Yuan Y; Hurria A; Peiguo C; Mortimer J; Chen S
J Steroid Biochem Mol Biol; 2017 Jun; 170():65-74. PubMed ID: 27154416
[TBL] [Abstract][Full Text] [Related]
9. Cancer "Avatars": Patient-Derived Xenograft Growth Correlation with Postoperative Recurrence and Survival in Pancreaticobiliary Cancer.
Lynch IT; Abdelrahman AM; Alva-Ruiz R; Fogliati A; Graham RP; Smoot R; Truty MJ
J Am Coll Surg; 2023 Sep; 237(3):483-500. PubMed ID: 37326316
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas.
Zeng W; Tang Z; Li Y; Yin G; Liu Z; Gao J; Chen Y; Chen F
Cancer Cell Int; 2020; 20():1. PubMed ID: 31908598
[TBL] [Abstract][Full Text] [Related]
11. Successful Secondary Engraftment of Pancreatic Ductal Adenocarcinoma and Cholangiocarcinoma Patient-Derived Xenografts After Previous Failed Primary Engraftment.
Hernandez MC; Yang L; Leiting JL; Sugihara T; Bergquist JR; Ivanics T; Graham R; Truty MJ
Transl Oncol; 2019 Jan; 12(1):69-75. PubMed ID: 30273859
[TBL] [Abstract][Full Text] [Related]
12. Patient-Derived Xenografts Can Be Reliably Generated from Patient Clinical Biopsy Specimens.
Hernandez MC; Bergquist JR; Leiting JL; Ivanics T; Yang L; Smoot RL; Nagorney DM; Truty MJ
J Gastrointest Surg; 2019 Apr; 23(4):818-824. PubMed ID: 30756315
[TBL] [Abstract][Full Text] [Related]
13. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
[TBL] [Abstract][Full Text] [Related]
14. Establishment and Characterization of Advanced Penile Cancer Patient-derived Tumor Xenografts: Paving the Way for Personalized Treatments.
Elst L; Van Rompuy AS; Roussel E; Spans L; Vanden Bempt I; Necchi A; Ross J; Jacob JM; Baietti MF; Leucci E; Albersen M
Eur Urol Focus; 2022 Nov; 8(6):1787-1794. PubMed ID: 35537937
[TBL] [Abstract][Full Text] [Related]
15. Patient-derived xenograft model engraftment predicts poor prognosis after surgery in patients with pancreatic cancer.
Chen Q; Wei T; Wang J; Zhang Q; Li J; Zhang J; Ni L; Wang Y; Bai X; Liang T
Pancreatology; 2020 Apr; 20(3):485-492. PubMed ID: 32113935
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of patient-derived head and neck cancer models from surgical specimens and endoscopic biopsies.
Strüder D; Momper T; Irmscher N; Krause M; Liese J; Schraven S; Zimpfer A; Zonnur S; Burmeister AS; Schneider B; Frerich B; Mlynski R; Große-Thie C; Junghanss C; Maletzki C
J Exp Clin Cancer Res; 2021 Aug; 40(1):246. PubMed ID: 34362423
[TBL] [Abstract][Full Text] [Related]
17. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
[TBL] [Abstract][Full Text] [Related]
18. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
Pergolini I; Morales-Oyarvide V; Mino-Kenudson M; Honselmann KC; Rosenbaum MW; Nahar S; Kem M; Ferrone CR; Lillemoe KD; Bardeesy N; Ryan DP; Thayer SP; Warshaw AL; Fernández-Del Castillo C; Liss AS
PLoS One; 2017; 12(8):e0182855. PubMed ID: 28854237
[TBL] [Abstract][Full Text] [Related]
19. Genomic and Molecular Signatures of Successful Patient-Derived Xenografts for Oral Cavity Squamous Cell Carcinoma.
Yen WC; Chang IY; Chang KP; Ouyang CN; Liu CR; Tsai TL; Zhang YC; Wang CI; Wang YH; Yu AL; Liu H; Wu CC; Chang YS; Yu JS; Yang CY
Front Oncol; 2022; 12():792297. PubMed ID: 35444950
[TBL] [Abstract][Full Text] [Related]
20. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.
Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A
Cells; 2019 Jun; 8(6):. PubMed ID: 31207870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]